Figure 2
From: Omentin: a biomarker of cardiovascular risk in individuals with axial spondyloarthritis
Omentin serum levels and cardiovascular risk factors. Differences in serum omentin levels between obese and non-obese axSpA patients (a), axSpA patients showing or not an AI indicative of dyslipidemia (AI ≥ 4) (b), and axSpA patients with and without IBD (c), after adjustment for potential confounding factors. Horizontal bars indicate the mean value of each group.
